Galantamine

acetylcholinesterase (Cartwright blood group) ; Homo sapiens







192 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33054569 Molecular networking based dereplication of AChE inhibitory compounds from the medicinal plant Vincetoxicum funebre (Boiss. & Kotschy). 2022 Mar 1
2 34971946 Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation. 2022 Feb 1
3 35098414 Alzheimer's disease therapy based on acetylcholinesterase inhibitor/blocker effects on voltage-gated potassium channels. 2022 Mar 2
4 35462270 A single-molecule with multiple investigations: Synthesis, characterization, computational methods, inhibitory activity against Alzheimer's disease, toxicity, and ADME studies. 2022 Apr 18 1
5 35527546 A Cobalt-Containing Compound as a Stronger Inhibitor than Galantamine to Inhibit Acetylcholinesterase Activity: A New Drug Candidate for Alzheimer's Disease Treatment. 2022 1
6 35563466 Kinetic Modeling of Time-Dependent Enzyme Inhibition by Pre-Steady-State Analysis of Progress Curves: The Case Study of the Anti-Alzheimer's Drug Galantamine. 2022 May 3 2
7 35595404 Pharmacogenetic studies in Alzheimer disease. 2022 May 1
8 35630613 Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors. 2022 May 13 2
9 32146656 Synthesis, biological evaluation, theoretical investigations, docking study and ADME parameters of some 1,4-bisphenylhydrazone derivatives as potent antioxidant agents and acetylcholinesterase inhibitors. 2021 Feb 1
10 33030113 Multi-target approach for Alzheimer's disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-N-phenylaminoquinoline derivative reveal promising potentials. 2021 Jul 1
11 33540879 Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer's Disease. 2021 Feb 2 1
12 33776997 The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial. 2021 1
13 33916760 Discovery of a Novel Acetylcholinesterase Inhibitor by Fragment-Based Design and Virtual Screening. 2021 Apr 3 1
14 34132933 Machine learning models to select potential inhibitors of acetylcholinesterase activity from SistematX: a natural products database. 2021 Aug 1
15 34299650 Bio-Guided Fractionation of Stem Bark Extracts from Phyllanthus muellarianus: Identification of Phytocomponents with Anti-Cholinesterase Activity. 2021 Jul 20 1
16 34363318 Structural Fractal Analysis of the Active Site of Acetylcholinesterase in Complexes with Huperzine A, Galantamine, and Donepezil. 2021 Nov 2
17 34443482 Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold. 2021 Aug 12 1
18 34628223 Synthesis, characterization, in vitro cholinesterase and hRBCs hemolysis assay and computational evaluation of novel 2,3,4,5-tetrahydrobenzothiazepine appended α-aminophosphonates. 2021 Nov 1
19 34664067 UHPLC With On-Line Coupled Biochemical Detection for High Throughput Screening of Acetylcholinesterase Inhibitors in Coptidis Rhizoma and Cortex Phellodendri. 2021 Oct 19 1
20 34755546 Synthesis, molecular modeling and cholinesterase inhibitory effects of 2-indolinone-based hydrazinecarbothioamides. 2021 Dec 1
21 31686175 Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects. 2020 Jan 2
22 31978679 Design, synthesis and evaluation of pyrazole bearing α-aminophosphonate derivatives as potential acetylcholinesterase inhibitors against Alzheimer's disease. 2020 Mar 1
23 32414155 Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future? 2020 May 13 1
24 32454229 Simple analogues of natural product chelerythrine: Discovery of a novel anticholinesterase 2-phenylisoquinolin-2-ium scaffold with excellent potency against acetylcholinesterase. 2020 Aug 15 1
25 32470371 Highly potent cholinesterase inhibition of geranylated xanthones from Garcinia fusca and molecular docking studies. 2020 Oct 2
26 32717861 Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors. 2020 Jul 23 3
27 32759369 Oral Pretreatment with Galantamine Effectively Mitigates the Acute Toxicity of a Supralethal Dose of Soman in Cynomolgus Monkeys Posttreated with Conventional Antidotes. 2020 Oct 1
28 32763546 Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement. 2020 Sep 1
29 32874532 QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine. 2020 1
30 33382027 Revealing the cholinergic inhibition mechanism of Alzheimer's by galantamine: a metadynamics simulation study. 2020 Dec 31 7
31 33488178 Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors. 2020 1
32 29697300 Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study. 2019 Apr 2
33 30101703 Phytoconstituents and their Possible Mechanistic Profile for Alzheimer's Disease - A Literature Review. 2019 1
34 30673880 Advances in Management of Psychosis in Neurodegenerative Diseases. 2019 Jan 23 1
35 30819081 Synthesis of New Galanthamine-Peptide Derivatives Designed for Prevention and Treatment of Alzheimer's Disease. 2019 1
36 30956012 Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment. 2019 Jun 1 1
37 31222828 Novel fluorine-containing chiral hydrazide-hydrazones: Design, synthesis, structural elucidation, antioxidant and anticholinesterase activity, and in silico studies. 2019 Aug 1
38 31315114 Effect of Rivastigmine (Acetyl Cholinesterase Inhibitor) versus Placebo on Manic Episodes in Patients with Bipolar Disorders: Results from a Double Blind, Randomized, Placebo-Controlled Clinical Trial. 2019 1
39 31847089 Synergistic Inhibition of Acetylcholinesterase by Alkaloids Derived from Stephaniae Tetrandrae Radix, Coptidis Rhizoma and Phellodendri Chinensis Cortex. 2019 Dec 13 2
40 28974110 Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer's Disease. 2018 Mar 1
41 29044771 Alkaloids of Amaryllidaceae as Inhibitors of Cholinesterases (AChEs and BChEs): An Integrated Bioguided Study. 2018 Mar 1
42 29286595 Galantamine and Computerized Cognitive Behavioral Therapy for Cocaine Dependence: A Randomized Clinical Trial. 2018 Jan/Feb 1
43 29570959 Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target Engagement. 2018 Mar 1 1
44 29635172 Combination of human acetylcholinesterase and serum albumin sensing surfaces as highly informative analytical tool for inhibitor screening. 2018 Jun 5 1
45 29655025 Design, facile synthesis, and evaluation of novel spiro- and pyrazolo[1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies. 2018 Jun 1
46 29723743 Spiropyrrolidine/spiroindolizino[6,7-b]indole heterocyclic hybrids: Stereoselective synthesis, cholinesterase inhibitory activity and their molecular docking study. 2018 Sep 1
47 29926988 Effects of galantamine on smoking behavior and cognitive performance in treatment-seeking smokers prior to a quit attempt. 2018 Jul 1
48 30079554 Synthesis, characterization, and SAR of arylated indenoquinoline-based cholinesterase and carbonic anhydrase inhibitors. 2018 Sep 1
49 30343499 Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors. 2018 Dec 1
50 30643787 Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia. 2018 Dec 1